Medical Devices Startups

ScreenPoint Medical develops deep learning software for breast cancer detection, with its Transpara product providing AI-based analysis of 2D and 3D mammography acquisitions across major equipment manufacturers. It serves radiologists and breast imaging providers to support breast screening and diagnostic workflows.

1 investor

SD BIOSENSOR is a company involved in sustainable management and economic value creation, publishing an annual sustainability management report. The page content available describes only its sustainability reporting rather than its core products or services.

1 investor

Sea4Us develops marine-derived treatments and compounds targeting unmet clinical needs. The company conducts research and development on marine organisms and their bioactive properties for pharmaceutical and healthcare applications.

1 investor

SeaSpine, a spine surgery products company, has become part of Orthofix. The page directs visitors to Orthofix.com for the expanded portfolio.

1 investor

Seaway Plastics Engineering is a contract manufacturing partner that provides full-service plastic product engineering, molding, and assembly for consumer products companies and OEMs. The company serves large innovators in the consumer products sector with expertise in supply chain coordination, quality control, and FDA-compliant manufacturing.

1 investor

Sebela Pharmaceuticals markets and distributes pharmaceutical products to healthcare providers throughout the United States, with select products also sold internationally through marketing partners.

1 investor

Sebia is an in vitro diagnostics company that develops equipment and reagents based on capillary electrophoresis technology for screening and monitoring diseases such as multiple myeloma, diabetes, hemoglobinopathies, and autoimmune and infectious diseases. It serves clinical diagnostic laboratories globally, focusing on chronic and metabolic conditions.

1 investor

Seegene is a molecular diagnostics company; this page is its investor relations section listing quarterly earnings release IR books available for download.

1 investor

This appears to be a research article or blog post from Seer Medical describing a study on using ECG (electrocardiogram) signals for seizure detection as an alternative to traditional EEG-based methods.

1 investor

Seerlinq provides a non-invasive home telemonitoring service for heart failure patients, using a device that analyzes photoplethysmography (PPG) signals to track cardiac filling pressures alongside a smartphone app and remote cardiology team. Its CE-marked HeartCore device detects worsening conditions early to prevent hospitalizations, and the service is available to heart failure patients across Slovakia.</parameter> <parameter name="founders">[{"full_name": "Allan Böhm", "title": "Co-founder (Cardiologist)"}, {"full_name": "Branislav Bezák", "title": "Co-founder (Cardiac Surgeon)"}, {"full_name": "Nikola Jajcay", "title": "Co-founder (Computer Scientist)"}]

1 investor

Vivid Vision builds a vision care platform that uses virtual reality technology to treat conditions such as amblyopia and strabismus. The system is used by eye doctors and distributed worldwide through regional partners.

1 investor

Seleon is a contract engineering and manufacturing partner for medical device companies across Central Europe, offering development, consulting, and production services for active/passive medical devices, in-vitro diagnostics, and combination products from concept to market launch.

1 investor

Selera Medical develops a minimally invasive implantable device that treats heart failure by removing excess fluid buildup, reducing hospitalizations and symptom recurrence through a single procedure.

1 investor

SelfSense makes SmartSplint, a CE-marked sensor technology that turns a standard protective dental splint into a device for measuring bruxism (tooth grinding), uploading the data to the cloud for analysis. It serves dentists and their patients, providing bruxism data to guide and customise dental treatment plans.

1 investor

Sêmeia builds MedicWise, a digital medical device for remote patient monitoring that automatically collects, structures, and analyzes health data for patients with chronic conditions. It serves physicians tracking chronic and long-term illness patients in France, with capabilities such as predicting kidney transplant rejection and graft survival.

1 investor

Semler Scientific develops FDA-cleared medical devices for early detection of vascular diseases, particularly peripheral arterial disease, serving healthcare providers and patients. The company manufactures point-of-care diagnostic systems and related software platforms for arterial blood flow measurement.

1 investor

Senex Biotechnology develops cancer and chronic disease therapies by targeting aging-related biological pathways identified through functional genomics. The company focuses on oncology indications including ovarian, breast, and prostate cancers.

1 investor

Seno Medical develops the Imagio Breast Imaging System, an opto-acoustic ultrasound imaging modality for diagnosing breast cancer without needles, dyes, or ionizing radiation. It is aimed at radiologists, breast imaging staff, and healthcare systems to reduce false-positive biopsies and provide a simplified diagnostic pathway for patients.

1 investor

SensID GmbH develops and manufactures reference materials and quality controls for DNA diagnostics. The company serves laboratory and diagnostic instrument developers who need precisely characterized materials for research, validation, accreditation, and conformity testing.

1 investor

Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs). The compound aims to improve on existing therapies like Epidiolex through better pharmacokinetics, reduced liver accumulation, and fewer drug-drug interactions.

1 investor

Sensars develops an implantable neurostimulation system that restores sensory feedback to the limbs by interfacing a proprietary intra-nerve electrode array with sensory nerve fibers, paired with wearable sensor insoles. The technology targets diabetic neuropathy and limb loss to reduce complications such as ulcers, falls, and amputations.

1 investor

Sense4Care develops wearable medical devices for movement disorder assessment, particularly Parkinson's Disease, using inertial measurement analysis. The company sells its STAT-ON product to hospitals, neurologists, and healthcare providers across Europe for objective symptom evaluation and disease management.

1 investor

Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.

1 investor

Senseye develops technology and tools for detecting and treating PTSD, leveraging neuroscience research and machine learning. The company serves mental health practitioners and trauma patients in the healthcare sector.

1 investor